Prostate Cancer Biomarkers and PVSA Research Presented
Fellow Health showcased innovative research, emphasizing mail-in semen testing to enhance prostate cancer diagnostics and PVSA care.
Read MorePosted by Chris Wolski | Apr 30, 2025 | Prostate |
Fellow Health showcased innovative research, emphasizing mail-in semen testing to enhance prostate cancer diagnostics and PVSA care.
Read MorePosted by Chris Wolski | Apr 23, 2025 | Prostate |
A new study confirms Cleveland Diagnostics’ IsoPSA test effectively differentiates between low- and high-risk prostate cancer patients.
Read MorePosted by Andy Lundin | Feb 3, 2025 | Prostate |
Lynx Dx announced at-home availability of a urine-based prostate cancer test that eliminates the need for a digital rectal exam.
Read MorePosted by Andy Lundin | Jan 29, 2025 | Prostate, Urinalysis & Toxicology |
A new study validated a urine test that offers a less invasive, more accurate alternative to traditional prostate cancer screening.
Read MorePosted by Andy Lundin | Jan 21, 2025 | Prostate |
A review found gaps remain for genomic classifier tests for their cost-effectiveness, clinical utility, and impact on diverse populations.
Read More